The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.
To read more About benefits and Risks go to https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19
Can anyone get a Paxlovid prescription? The FDA authorized Paxlovid for people ages 12 and older who weigh at least 88 pounds. But in order to qualify for a prescription, you must also have had a positive COVID-19 test result and be at high risk for developing severe COVID-19.
To check if you qualify for a prescription simply call 📞 your Doctor or just fill out this form and we'll be glad to help you. https://form.jotform.com/221178954020149
We love our customers, so feel free to visit during normal business hours.
9320 US-19 hwy, Port Richey, FL 34668, United States
09:00 am – 05:00 pm
Copyright © 2022 Embassy Compounding Pharmacy - All Rights Reserved.